{"id":"doi:10.1016/s2213-8587(22)00008-0","kind":"article","title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","authors":["Takashi Kadowaki","Joakim Isendahl","Usman Khalid","Sang Yeoup Lee","Tomoyuki Nishida","Wataru Ogawa","Kazuyuki Tobe","Toshimasa Yamauchi","Soo Kyung Lim"],"author_count":9,"year":2022,"published":"2022-02-04","venue":"The Lancet Diabetes & Endocrinology","cited_by":330,"doi":"10.1016/s2213-8587(22)00008-0","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s2213-8587(22)00008-0","archive_url":"https://space-kitty.com/papers/doi:10.1016/s2213-8587(22)00008-0","updated":null,"pmid":"35131037","pmcid":null,"openalex_id":"W4210417346","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}